Small But Mighty: Targeting Lp(a) for Atherosclerotic Cardiovascular Disease Risk Reduction

This presentation is aimed to
1. Describe the clinical significance of lipoprotein(a) and its role
in the development of atherosclerotic cardiovascular disease, and
2. Describe current and investigational pharmacotherapies that
lower lipoprotein(a)